These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 14597934

  • 1. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
    Haas SJ, Vos T, Gilbert RE, Krum H.
    Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
    [Abstract] [Full Text] [Related]

  • 2. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J, MERIT-HF Study Group.
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H, Demets D, Deedwania P, Fagerberg B, Goldstein S, Gottlieb S, Hjalmarson A, Kjekshus J, Waagstein F, Wikstrand J, MERIT-HF Study Group.
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [Abstract] [Full Text] [Related]

  • 5. Influence of global region on outcomes in heart failure β-blocker trials.
    O'Connor CM, Fiuzat M, Swedberg K, Caron M, Koch B, Carson PE, Gattis-Stough W, Davis GW, Bristow MR.
    J Am Coll Cardiol; 2011 Aug 23; 58(9):915-22. PubMed ID: 21851879
    [Abstract] [Full Text] [Related]

  • 6. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct 23; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ, Dietz R.
    Z Kardiol; 1997 Jan 23; 86(1):1-8. PubMed ID: 9133118
    [Abstract] [Full Text] [Related]

  • 8. Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers.
    Bobbio M, Ferrua S, Opasich C, Porcu M, Lucci D, Scherillo M, Tavazzi L, Maggioni AP, BRING-UP Investigators.
    J Card Fail; 2003 Jun 23; 9(3):192-202. PubMed ID: 12815569
    [Abstract] [Full Text] [Related]

  • 9. Use of beta-blockers for heart failure in patients with diabetes mellitus.
    Giles TD.
    Postgrad Med; 2002 Nov 23; 112(5 Suppl Unanswered):32-7. PubMed ID: 19667606
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 23; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 13. Type 2 diabetes mellitus and heart failure.
    Choy CK, Rodgers JE, Nappi JM, Haines ST.
    Pharmacotherapy; 2008 Feb 23; 28(2):170-92. PubMed ID: 18225964
    [Abstract] [Full Text] [Related]

  • 14. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
    Bell DS, Lukas MA, Holdbrook FK, Fowler MB.
    Curr Med Res Opin; 2006 Feb 23; 22(2):287-96. PubMed ID: 16466600
    [Abstract] [Full Text] [Related]

  • 15. Beta-blocker therapy in heart failure in the elderly.
    Fu M.
    Int J Cardiol; 2008 Apr 10; 125(2):149-53. PubMed ID: 18023898
    [Abstract] [Full Text] [Related]

  • 16. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
    Juul AB, Wetterslev J, Kofoed-Enevoldsen A, Callesen T, Jensen G, Gluud C, Diabetic Postoperative Mortality and Morbidity group.
    Am Heart J; 2004 Apr 10; 147(4):677-83. PubMed ID: 15077084
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L, Wikstrand J, Deedwania P, Hjalmarson A, Egstrup K, Elkayam U, Gottlieb S, Rashkow A, Wedel H, Bermann G, Kjekshus J, MERIT-HF Study Group.
    J Am Coll Cardiol; 2005 Jan 18; 45(2):252-9. PubMed ID: 15653024
    [Abstract] [Full Text] [Related]

  • 19. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL, Baker WL, White CM.
    Curr Med Res Opin; 2007 Jun 18; 23(6):1239-44. PubMed ID: 17559720
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.